MSF South Asia 43d ago

Since June 2025, MSF has been using PANAF, a WHO‑prequalified antivenom, and conducting a study to assess its effectiveness in treating snakebite envenoming. The findings of this study will be shared with health authorities and relevant stakeholders in June 2026, contributing to improved access to safe and effective snakebite care.